Globus Medical GMED Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $12.57M+42.6% | $8.81M+442% | -$2.58M-0.7% | -$2.56M-0.9% | -$2.54M+39.7% | ||
| $586.71M+9.1% | $537.87M+26.9% | $423.78M+18.8% | $356.65M+92.2% | $185.56M+80.2% | ||
| $814.25M+7.6% | $756.66M+17.1% | $646.17M+16.9% | $552.73M+6.5% | $518.78M+23.7% | ||
| $533.2M+11.1% | $479.82M+29.4% | $370.75M+31.7% | $281.49M+10.4% | $255M+53.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Globus Medical's revenue?
- Globus Medical (GMED) generated $3.1B in revenue over the trailing twelve months, up 23.5% year over year.
- Is Globus Medical profitable?
- Globus Medical reported $586.7M in net income over the trailing twelve months, a 18.9% net margin.
- What are Globus Medical's profit margins?
- Gross margin is 67.9% and operating margin is 17.2%, with a 18.9% net margin.
- What is Globus Medical's earnings per share?
- Globus Medical's diluted EPS over the trailing twelve months is $4.29.
- Where does Globus Medical's income statement data come from?
- Every line is extracted from Globus Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
